Dr. Harender Kumar Kalonia, MD

Dr. Kalonia practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Kalonia's NPI, 1346626355, was assigned on August 3, 2015. Dr. Kalonia holds Massachusetts license 286675.

Dr. Kalonia's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Kalonia's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Kalonia is also affiliated with Rochester General Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Kalonia to 1 more hospital, 3 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalonia practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kalonia's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Kalonia's licenses on file in 2 states: Massachusetts and New York.

CMS data shows 1,126 Medicare services from Dr. Kalonia across 8 procedure codes in 2024, for 437 Medicare patients. Medicare paid $112,412 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 437 Medicare patients who saw Dr. Kalonia in 2024. The largest group is 85 and over, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalonia's median patient age at 74, with 52% women.

In 2024, Dr. Kalonia wrote 238 Medicare Part D claims for 112 patients. 88% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $314 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kalonia for performance year 2024, reported as part of a group. Dr. Kalonia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Kalonia from 2 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $43.